The International Cancer Proteogenomic Consortium (ICPC)
The European Cancer Mooonshot Center is a member of the International Cancer Proteogenome Consortium (ICPC) that is a collaborative scientific organization that serves as a platform for cooperation among some of the world’s leading cancer and proteogenomic research centers. Emerged as a response to the Cancer MoonshotSM initiative, which aimed to foster global collaboration and investments in cancer research, as well as advancements in precision medicine, the ICPC was established in late 2016.
https://icpc.cancer.gov/portal/
Launched in late 2016, the International Cancer Proteogenomic Consortium (ICPC) was catalysed by the initial efforts of Cancer Moonshot, US. The ICPC is a scientific organisation that provides a forum for collaboration between some of the leading international cancer and proteogenomic research centres. The main focus of the ICPC organisation are the following:
- To encourage international cooperation and investment amongst nations in cancer research and cancer care.
- Bring together leading scientists for new efforts in precision medicine.
- Collaboration within the application of proteogenomic analysis in predicting cancer treatment success and to share data and results with researchers worldwide, ultimately hastening treatment progress for patients.
Cancer Moonshot Lund, Sweden is a member of ICPC that also includes teams in Australia, Canada, China, Germany, Japan, South Korea, Switzerland, Taiwan, United Kingdom and the United States.
CANCER MOONSHOT MEETING IN DRESDEN, GERMANY 2024
Uniting cancer research labs worldwide in the fight against cancer! The National Cancer Institute (NCI) International Cancer ProteoGenome Consortium (ICPC) just wrapped its annual meeting in Dresden, Germany. Progress made, still more to tackle… as cancer has no borders.
Cancer Moonshot – ICPC Summit in SEOUL, KOREA 2023
Start of the NIH-Cancer Moonshot ICPC-2023 Summit in Seoul
ICPC meeting 2022
ICPC meeting 2017
All nations present at the ICPC meeting, HUPO 2017, Dublin, Ireland
Cancer Moonshot Lund, Sweden is a member of ICPC that also includes teams in Australia, Canada, China, Germany, Japan, South Korea, Switzerland, Taiwan, United Kingdom and the United States.
___
READ MORE
https://proteomics.cancer.gov/
https://proteomics.cancer.gov/node/14
https://proteomics.cancer.gov/news_and_announcements/applied-proteogenomics-organizational-learning-and-outcomes-apollo-network